ONCO3 Statistics

Total Valuation

Oncoclínicas do Brasil Serviços Médicos has a market cap or net worth of BRL 2.11 billion. The enterprise value is 6.13 billion.

Market Cap	2.11B
Enterprise Value	6.13B

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Oncoclínicas do Brasil Serviços Médicos has 632.79 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	632.79M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.65%
Owned by Institutions (%)	49.55%
Float	448.27M

Valuation Ratios

The trailing PE ratio is 27.02 and the forward PE ratio is 6.22. Oncoclínicas do Brasil Serviços Médicos's PEG ratio is 0.09.

PE Ratio	27.02
Forward PE	6.22
PS Ratio	0.32
PB Ratio	0.56
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.09

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.27, with an EV/FCF ratio of -9.25.

EV / Earnings	84.66
EV / Sales	1.01
EV / EBITDA	6.27
EV / EBIT	8.17
EV / FCF	-9.25

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 1.40.

Current Ratio	1.96
Quick Ratio	1.80
Debt / Equity	1.40
Debt / EBITDA	5.87
Debt / FCF	-8.77
Interest Coverage	1.13

Financial Efficiency

Return on equity (ROE) is 3.79% and return on invested capital (ROIC) is 5.87%.

Return on Equity (ROE)	3.79%
Return on Assets (ROA)	4.57%
Return on Capital (ROIC)	5.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.58
Inventory Turnover	22.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.37% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-63.37%
50-Day Moving Average	4.72
200-Day Moving Average	6.95
Relative Strength Index (RSI)	20.41
Average Volume (20 Days)	4,309,380

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oncoclínicas do Brasil Serviços Médicos had revenue of BRL 6.10 billion and earned 72.39 million in profits. Earnings per share was 0.12.

Revenue	6.10B
Gross Profit	2.04B
Operating Income	762.75M
Pretax Income	178.94M
Net Income	72.39M
EBITDA	926.23M
EBIT	762.75M
Earnings Per Share (EPS)	0.12

Full Income Statement

Balance Sheet

The company has 2.16 billion in cash and 5.81 billion in debt, giving a net cash position of -3.66 billion or -5.78 per share.

Cash & Cash Equivalents	2.16B
Total Debt	5.81B
Net Cash	-3.66B
Net Cash Per Share	-5.78
Equity (Book Value)	4.16B
Book Value Per Share	5.99
Working Capital	2.44B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -421.64 million and capital expenditures -240.96 million, giving a free cash flow of -662.60 million.

Operating Cash Flow	-421.64M
Capital Expenditures	-240.96M
Free Cash Flow	-662.60M
FCF Per Share	-1.05

Full Cash Flow Statement

Margins

Gross margin is 33.54%, with operating and profit margins of 12.51% and 1.19%.

Gross Margin	33.54%
Operating Margin	12.51%
Pretax Margin	2.94%
Profit Margin	1.19%
EBITDA Margin	15.20%
EBIT Margin	12.51%
FCF Margin	-10.87%

Dividends & Yields

Oncoclínicas do Brasil Serviços Médicos does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	45.63%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.70%
FCF Yield	-31.44%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Oncoclínicas do Brasil Serviços Médicos has an Altman Z-Score of 1.27. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.27
Piotroski F-Score	n/a